DA agonists ‐ Ergot derivaties: Lisuride

@article{Goetz2002DAA,
  title={DA agonists ‐ Ergot derivaties: Lisuride},
  author={Christopher G. Goetz and William C. Koller and Werner Poewe and Olivier Rascol and Cristina Sampaio and Mitchell F Brin and Andrew John Lees and Peter LeWitt and Andres M. Lozano and Yoshikuni Mizuno and John G. Nutt and Wolfgang Hermann Oertel and C. Warren Olanow and Eduardo Tolosa},
  journal={Movement Disorders},
  year={2002},
  volume={17}
}
3 Citations

What’s in the pipeline for the treatment of Parkinson’s disease?

TLDR
This review examines the current state of development of potential PD therapies, including dopaminergic therapies, modulators of adenosine and glutamate receptors, cell-based therapies, genetic therapies and device- based therapies.